Physician–scientists at the University of Utah's John A. Moran Eye Center have published an investigatory review of nine patients who experienced vision complications while taking popular semaglutide ...

The US Food and Drug Administration (FDA) has approved a new pain medication, suzetrigine, marking the first new type of pain reliever to be approved in over 20 years.The drug, sold under the brand ...

Worldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around 4 in every 10 patients treated with these drugs, suggests a pooled data analysis of the ...

C&EN’s tabulation follows approvals from the FDA’s Center for Drug Evaluation and Research; therefore, it does not include blood products, gene therapies, vaccines, and other therapies that ...

Polyneuropathy is also known as peripheral neuropathy. Peripheral nerves are ... Available treatments include medication, medical therapies and procedures, and alternative treatments.

ART26.12 is being developed specifically for chemotherapy-induced peripheral neuropathy, which remains a serious adverse problem for patients during cancer therapy and post therapy. Dr. Ojima and ...

Trump’s Justice Department could reinstate the protocol to use pentobarbital as a single drug to carry out executions. A moratorium on federal executions has been in place since 2021, and only three ...

BACOLOD CITY — A total of 19 employees of Negros Occidental provincial government tested positive for illegal drug use, data provided by lawyer Rayfrando Diaz II, provincial administrator, showed. Of ...

Data were obtained for 16,827 patients, including 710 with T2D (194 prescribed semaglutide; 516 prescribed non-glucagon like peptide 1 receptor agonist [GLP1-RA] antidiabetic medications ...

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Free seminar! Strategies to Help Enhance Your Job Search ...